Alumis, Inc. (ALMS)
7.085
-0.20
(-2.81%)
USD |
NASDAQ |
Sep 25, 14:11
Alumis Cash from Operations (TTM) : -351.40M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -351.40M |
| March 31, 2026 | -376.25M |
| December 31, 2025 | -369.52M |
| September 30, 2025 | -372.38M |
| June 30, 2025 | -345.24M |
| March 31, 2025 | -291.17M |
| Date | Value |
|---|---|
| December 31, 2024 | -255.08M |
| September 30, 2024 | -214.04M |
| June 30, 2024 | -163.52M |
| March 31, 2024 | -139.57M |
| December 31, 2023 | -129.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Johnson & Johnson | 27.61B |
| Corcept Therapeutics, Inc. | 109.70M |
| Aclaris Therapeutics, Inc. | -62.06M |
| BioAge Labs, Inc. | -87.60M |
| ANI Pharmaceuticals, Inc. | 189.47M |